These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 9505825)

  • 41. Different subsets of tumor-infiltrating lymphocytes correlate with macrophage influx and monosomy 3 in uveal melanoma.
    Bronkhorst IH; Vu TH; Jordanova ES; Luyten GP; Burg SH; Jager MJ
    Invest Ophthalmol Vis Sci; 2012 Aug; 53(9):5370-8. PubMed ID: 22743317
    [TBL] [Abstract][Full Text] [Related]  

  • 42. NKT cells act through third party bone marrow-derived cells to suppress NK cell activity in the liver and exacerbate hepatic melanoma metastases.
    Sadegh L; Chen PW; Brown JR; Han Z; Niederkorn JY
    Int J Cancer; 2015 Sep; 137(5):1085-94. PubMed ID: 25683463
    [TBL] [Abstract][Full Text] [Related]  

  • 43. PRAME as a Potential Target for Immunotherapy in Metastatic Uveal Melanoma.
    Gezgin G; Luk SJ; Cao J; Dogrusöz M; van der Steen DM; Hagedoorn RS; Krijgsman D; van der Velden PA; Field MG; Luyten GPM; Szuhai K; Harbour JW; Jordanova ES; Heemskerk MHM; Jager MJ
    JAMA Ophthalmol; 2017 Jun; 135(6):541-549. PubMed ID: 28448663
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Associated expression of HLA class I and class II antigens on melanoma cells in surgically removed metastases.
    van Duinen SG; Ruitter DJ; Ferrone S
    J Pathol; 1986 Aug; 149(4):339-48. PubMed ID: 3531448
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inverse correlation between expression of HLA-B and c-myc in uveal melanoma.
    Blom DJ; Mooy CM; Luyten GP; Kerkvliet S; Ouwerkerk I; Zwinderman AH; Schrier PI; Jager MJ
    J Pathol; 1997 Jan; 181(1):75-9. PubMed ID: 9072006
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Possible relation between HLA and ABO type and prognosis of uveal melanoma.
    Jager MJ; Völker-Dieben HJ; de Wolff-Rouendaal D; Kakebeeke-Kemme H; D'Amaro J
    Doc Ophthalmol; 1992; 82(1-2):43-7. PubMed ID: 1305026
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Loss of monomorphic and polymorphic HLA antigens in metastatic breast and colon carcinoma.
    Goepel JR; Rees RC; Rogers K; Stoddard CJ; Thomas WE; Shepherd L
    Br J Cancer; 1991 Nov; 64(5):880-3. PubMed ID: 1718386
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical responses and lymphoid infiltrates in metastatic melanoma following treatment with intralesional GM-CSF.
    Si Z; Hersey P; Coates AS
    Melanoma Res; 1996 Jun; 6(3):247-55. PubMed ID: 8819128
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Expression of transporters associated with antigen processing and human leucocyte antigen class I in malignant melanoma and its association with prognostic factors.
    Tao J; Li Y; Liu YQ; Li L; Liu J; Shen X; Shen GX; Tu YT
    Br J Dermatol; 2008 Jan; 158(1):88-94. PubMed ID: 17999701
    [TBL] [Abstract][Full Text] [Related]  

  • 50. High numbers of tumour-infiltrating activated cytotoxic T lymphocytes, and frequent loss of HLA class I and II expression, are features of aggressive B cell lymphomas of the brain and testis.
    Riemersma SA; Oudejans JJ; Vonk MJ; Dreef EJ; Prins FA; Jansen PM; Vermeer MH; Blok P; Kibbelaar RE; Muris JJ; Schuuring EM; Kluin PM
    J Pathol; 2005 Jul; 206(3):328-36. PubMed ID: 15887291
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Differential expression of HLA class I and II antigens in primary and metastatic melanomas.
    Lopez Nevot MA; Garcia E; Pareja E; Bonal FJ; Martin J; Ruiz-Cabello F; Serrano S; Garrido F
    J Immunogenet; 1986; 13(2-3):219-27. PubMed ID: 3102617
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Differential expression of HLA-A and B-alleles on uveal melanoma as determined by immuno-histology.
    de Waard-Siebinga I; Houbiers JG; Hilders CG; de Wolff-Rouendaal D; Jager MJ
    Ocul Immunol Inflamm; 1996; 4(1):1-14. PubMed ID: 22827328
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immunohistologic responses within dermal metastatic melanoma lesions of patients treated with a synthetic peptide vaccine.
    Fritsch M; Rosenberg SA; Duray PH
    J Immunother; 2000; 23(5):557-69. PubMed ID: 11001549
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Expression of HLA antigens in paraffin sections of uveal melanomas.
    Jager MJ; de Wolff-Rouendaal D; Breebaart AC; Ruiter DJ
    Doc Ophthalmol; 1986 Dec; 64(1):69-76. PubMed ID: 3556115
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Detection of surface antigens in uveal melanoma using monoclonal antibodies].
    Cernák A; Kalafut F; Kusenda J; Novotná L
    Cesk Oftalmol; 1989 May; 45(3):145-52. PubMed ID: 2743434
    [TBL] [Abstract][Full Text] [Related]  

  • 56. MICA triggering signal for NK cell tumor lysis is counteracted by HLA-G1-mediated inhibitory signal.
    Menier C; Riteau B; Carosella ED; Rouas-Freiss N
    Int J Cancer; 2002 Jul; 100(1):63-70. PubMed ID: 12115588
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Decreased intraindividual HLA class I expression is due to reduced transcription in advanced melanoma and does not correlate with HLA-G expression.
    Willers J; Urosevic M; Laine E; Geertsen R; Kündig T; Burg G; Dummer R
    J Invest Dermatol; 2001 Dec; 117(6):1498-504. PubMed ID: 11886514
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Expression of Fas and Fas ligand in uveal melanoma: biological implication and prognostic value.
    Anastassiou G; Coupland SE; Stang A; Boeloeni R; Schilling H; Bornfeld N
    J Pathol; 2001 Aug; 194(4):466-72. PubMed ID: 11523055
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Expression of HLA-A2 antigen in human melanoma cell lines and its role in T-cell recognition.
    Pandolfi F; Boyle LA; Trentin L; Kurnick JT; Isselbacher KJ; Gattoni-Celli S
    Cancer Res; 1991 Jun; 51(12):3164-70. PubMed ID: 1904004
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of hyperthermia on expression of histocompatibility antigens and heat-shock protein molecules on three human ocular melanoma cell lines.
    Blom DJ; De Waard-Siebinga I; Apte RS; Luyten GP; Niederkorn JY; Jager MJ
    Melanoma Res; 1997 Apr; 7(2):103-9. PubMed ID: 9167175
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.